UK|CLEAR Advises Department of Health and MHRA on Definition of Cannabis-Derived Medicinal Products. – CLEAR

 

Last week, CLEAR was invited to participate in a teleconference with representatives of the Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA). This followed our written submissions made over the last few weeks.

Webp.net-gifmakerThe teleconference included two representatives from each party. The DHSC was represented by the Medicines Pharmacy and Industry section. The MHRA was represented by the Licensing Division.

CLEAR has now submitted a summary of all the advice offered which is reproduced below.

READ MORE BELOW:

Source: https://ift.tt/2xkiH8i reposted by Cannabis News World . Original article by

 

Advertisements

This site uses Akismet to reduce spam. Learn how your comment data is processed.